BMS-690514

DB11665InvestigationalSmall molecule

BMS-690514 has been investigated for the treatment of Breast Cancer.

Mechanism: Pharmacologically active on Receptor tyrosine-protein kinase erbB-4, Vascular endothelial growth factor receptor, and Receptor tyrosine-protein kinase erbB-2
Curator reviewed
Formula / weight: C₁₉H₂₄N₆O₂ · 368.441 g/mol (avg)
Code names: BMS-690514

Resolves to

Compound

Structure

InChIKeyCSGQVNMSRKWUSH-IAGOWNOFSA-NSMILESCOC1=CC=CC(NC2=NC=NN3C=CC(CN4CC[C@@H](N)[C@H](O)C4)=C23)=C1

Targets

What you can answer from here — as of June 15, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

18+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-690514, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.